Post Profile






Congress just gave the maker of EpiPen another nasty deadline (MYL)

The headaches will continue at Mylan until transparency improves. Congressmen Jason Chaffetz (R-UT) and Elijah Cummings (D-MD) have sent the maker of EpiPen a letter requesting additional documents clarifying the company's pricing structure. This after the House Oversight Committee held a hearing with Mylan's CEO, Heather Bresch that left it with more questions than answers.
read more

share

Related Posts


Not everyone is buying into Mylan's EpiPen price plan (MYL)

Business & Finance : Business Insider: Money Game

Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount for a two-pack of EpiPens, amid pressure to cut the price of the drug. Mylan has increased the price of EpiPen by 500% since it acquired the ...

Mylan's decision to make a cheaper, generic EpiPen 'baffles' experts (MYL)

Business & Finance : Business Insider: Clusterstock

Mylan, the drugmaker feeling the heat over its pricing of the EpiPen, said Monday that it will make an "authorized generic" version of the EpiPen that will cost $300 for a two-pack. It will also continue to produce its branded versi...

The Mylan CEO's senator father backs away from drug price discussions (MYL)

Business & Finance : Business Insider: Money Game

The pharmaceutical company Mylan has been in the hot seat with members of Congress over the price of the EpiPen. The device, used in emergencies to treat severe allergic reactions, costs more than 500% more than it did when Mylan ac...

The numbers the maker of EpiPen just released expose yet another load of nonsense (MYL)

Business & Finance : Business Insider: Money Game

I didn't believe it when I heard it, and you probably didn't either — but America was forced to humor the CEO of Mylan when she told Congress that she raised the price of an EpiPen to improve access for patients, not to make money. ...

The maker of the EpiPen is being investigated for antitrust violations in New York (MYL)

Business & Finance : Business Insider: Clusterstock

Anger over high drug prices has put EpiPen maker Mylan in the news recently, but the company is now being investigated over another potential issue altogether. The price of the EpiPen, a device used in emergencies to treat severe al...

Comments


Copyright © 2016 Regator, LLC